Erin Babcock

Erin Babcock is a highly experienced professional in the field of clinical operations and research, holding significant roles at multiple prestigious organizations. At Inhibrx Biosciences, Inc., Erin serves as a Senior Clinical Director. Prior experience includes positions such as Senior Clinical Scientist at Bristol Myers Squibb and Associate Director of Clinical Operations at Celgene. Erin has also contributed to the success of Intercept Pharmaceuticals while serving in various capacities, including Director and Associate Director of Clinical Operations, as well as Manager of Clinical Operations. Earlier in the career, Erin held the role of Clinical Trial Manager at Eli Lilly and Company.